Shanghai Kindly Entrp Dvlp Grp

Shanghai Kindly Entrp Dvlp Grp

603987 · SHG · Healthcare / Medical Instruments & Supplies

7.12CNY-0.06 (-0.84%)

Price History

Full chart

Market Stats

Previous Close7.18
Open7.20
Day Range7.09 – 7.22
52-Week Range6.72 – 9.60
Volume3.15M
Market Cap3.32B
P/E (TTM)14.32
Forward P/E0.00
EPS0.53
Dividend Yield2.24%
Beta0.32
50-Day Avg7.47
200-Day Avg8.18

About

Shanghai Kindly Enterprise Development Group Co.,LTD. researches, develops, produces, sells, medical devices such as medical puncture needles and medical infusion devices worldwide. It offers syringes, infusion sets, needles, and tube bags. The company also provides medical packing films, sterilization indicator tapes and needles; and intervention accessories, such as stopcocks. In addition, it offers disposable coaxial biopsy needle, therapy device, disposable pump infusion sets, pharmaceutical packaging materials, drug liquid transfer devices, needle-proof prefilled syringe assemblies, polypropylene prefilled injection, disposable water delivery tube, indwelling needles, disposable anti-needle injection and pen needle, micro needle, disposable skin-penetrating guide needles and syringes, radiofrequency treatment puncture needle, visual double-lumen endotracheal tube, disposable reflux indwelling needle, root irrigation needle, disposable arterial blood gas needle, compression hemostatic device. Further, it offers puncture care, infusion catheters, indwelling infusions, puncture intervention, medical beauty, and medicine bags. The company exports its products to the United States, Europe, South America, the Middle East, Southeast Asia, and internationally. The company is headquartered in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Wei Xin Zhang
  • Employees3.50K
  • HeadquartersBuilding 1, No. 658 Gaochao Road, Shanghai, China, 201803, China
  • Websitehttps://www.kdlchina.cn

Leadership

  • Mr. Wei Xin ZhangGM & Director · b. 1973
  • Mr. Jian Yong XiangVice Chairman & Deputy GM · b. 1974
  • Mr. Xiaoru ShenCFO, Financial Director & Accounting Supervisor · b. 1984
  • Mr. Yong ZhangDeputy GM & Director · b. 1971
  • Ms. Gu JiajunBoard Secretary · b. 1985

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue775.52M882.93M931.95M982.79M1.06B1.13B1.26B1.45B1.82B2.65B3.10B3.12B2.45B2.26B2.30B
Growth (%)-+13.85%+5.55%+5.46%+8.00%+6.66%+10.98%+15.41%+25.30%+45.60%+17.07%+0.70%-21.36%-7.79%+1.63%
Cost of Revenue558.55M642.42M675.74M706.92M734.09M759.21M836.22M944.60M1.13B1.66B1.91B2.08B1.66B1.54B1.54B
Gross Profit216.97M240.50M256.21M275.87M327.32M372.87M420.18M505.46M687.09M986.68M1.19B1.04B793.91M726.20M759.93M
Gross Margin27.98%27.24%27.49%28.07%30.84%32.94%33.44%34.86%37.82%37.30%38.27%33.47%32.37%32.11%33.06%
Operating Expense130.43M148.88M206.03M198.89M207.24M235.24M259.30M304.09M404.85M606.21M707.35M644.27M492.91M471.15M468.91M
Operating Income86.54M91.62M50.18M76.98M120.08M137.63M160.88M201.37M282.24M380.46M478.01M399.46M301.00M255.06M291.02M
Operating Margin11.16%10.38%5.38%7.83%11.31%12.16%12.80%13.89%15.53%14.38%15.43%12.81%12.27%11.28%12.66%
EBITDA140.95M115.76M152.68M167.18M210.20M229.24M244.10M280.98M389.51M525.07M635.68M565.96M474.00M423.44M481.57M
EBITDA Margin18.17%13.11%16.38%17.01%19.80%20.25%19.43%19.38%21.44%19.85%20.53%18.15%19.33%18.72%20.95%
Net Income75.28M57.17M63.31M64.48M94.55M100.71M118.96M147.09M170.10M202.77M291.40M311.74M230.90M215.33M240.35M
Net Income Margin9.71%6.47%6.79%6.56%8.91%8.90%9.47%10.14%9.36%7.67%9.41%10.00%9.41%9.52%10.46%
R&D-36.67M43.10M42.09M47.70M49.01M52.77M73.57M89.13M124.24M165.43M123.00M100.55M106.21M90.48M
R&D as % of Total Revenue-4.15%4.63%4.28%4.49%4.33%4.20%5.07%4.91%4.70%5.34%3.94%4.10%4.70%3.94%
Interest Expense18.64M023.94M22.75M18.01M18.50M1.99M440.44K16.00M23.09M26.28M31.10M28.16M23.62M17.02M
Interest Expense % of Total Revenue2.40%0.00%2.57%2.32%1.70%1.63%0.16%0.03%0.88%0.87%0.85%1.00%1.15%1.04%0.74%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets896.08M968.67M1.14B1.25B1.36B1.55B1.60B2.17B3.77B4.26B4.96B4.14B4.22B4.15B4.19B
Total Liabilities500.30M512.96M612.85M576.73M560.97M319.07M261.18M546.07M1.07B1.29B1.57B1.59B1.44B1.24B1.14B
Total Equity372.42M428.83M493.59M621.91M722.07M1.14B1.23B1.37B1.60B1.76B2.08B2.23B2.41B2.54B2.72B
Cash96.23M78.55M117.70M153.45M170.08M356.84M351.41M726.58M1.08B1.24B1.01B419.67M508.72M368.13M491.95M
Total Debt374.20M391.00M358.91M369.94M375.50M101.00M1.30M203.40M461.18M566.03M697.77M776.78M765.42M572.04M-
Net Debt277.97M312.45M241.21M216.49M205.42M-255.85M-350.11M-523.18M-615.23M-673.25M-308.21M357.11M256.70M203.92M57.40M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow49.14M112.40M146.36M124.69M147.16M234.71M183.27M314.17M256.37M403.28M408.97M461.74M450.07M292.49M407.64M
Investing Cash Flow-169.36M-119.08M-39.28M-102.66M-103.01M-75.15M-120.89M-197.10M-655.64M-206.95M-728.37M-973.47M-195.72M-149.75M-
Financing Cash Flow150.35M-13.81M-66.70M11.29M-24.58M21.69M-131.96M302.45M739.65M-19.62M96.39M-131.85M-140.32M-273.38M-
Capital Expenditure162.15M119.48M149.69M116.62M104.84M75.66M124.55M179.96M218.96M332.20M654.04M296.43M228.02M143.62M146.58M
Free Cash Flow-113.01M-7.08M-3.33M8.08M42.32M159.04M58.73M134.21M37.41M71.08M-245.07M165.31M211.59M148.87M261.06M
Dividends Paid18.92M27.55M28.17M23.32M32.86M156.22M33.66M47.58M66.24M65.38M24.62M135.46M122.89M94.03M83.11M
FCF to OCF-230.00%-6.30%-2.28%6.48%28.76%67.76%32.04%42.72%14.59%17.63%-59.92%35.80%47.01%50.90%64.04%
Dividend Paid to FCF-16.74%-389.10%-845.41%288.70%77.65%98.23%57.32%35.45%177.07%91.97%-10.05%81.94%58.08%63.16%31.84%

Earnings

Report DateDec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Mar 31, 2020Apr 28, 2020Aug 18, 2020Oct 27, 2020Mar 29, 2021Apr 27, 2021Aug 25, 2021Oct 26, 2021Mar 30, 2022Apr 25, 2022Aug 25, 2022Oct 26, 2022Apr 18, 2023
EPS Estimate-------------------------
EPS Actual0.050.050.070.080.060.060.090.110.080.070.100.100.120.070.140.210.120.100.180.200.180.160.240.180.13
Surprise-------------------------
Timing------------After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap3.32B
Enterprise Value3.46B
Trailing P/E14.32
Forward P/E0.00
Price / Sales1.47
Price / Book1.17
EPS0.53
Book Value6.48
Revenue (TTM)2.26B
Gross Profit (TTM)726.36M
EBITDA402.38M
Profit Margin10.06%
Operating Margin11.06%
Return on Equity8.07%
Return on Assets3.81%
Shares Outstanding436.79M
Shares Float248.66M
Beta0.32
Dividend Yield2.24%
Dividend Rate0.17
Payout Ratio32.08%

Dividends

20231×
0.22Jun 20, 2023
20221×
0.20Jun 29, 2022
20201×
0.15May 21, 2020
20191×
0.15May 10, 2019
20181×
0.15Jul 18, 2018
20171×
0.11Jun 8, 2017

Stock Splits

  • Jul 18, 20187:5
  • Jun 8, 20173:2